Currently out of the existing stock ratings of Jennifer Kim, 56 are a BUY (98.25%), 1 are a HOLD (1.75%).

Jennifer Kim

Work Performance Price Targets & Ratings Chart

Analyst Jennifer Kim, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 29.23% that have a potential upside of 61.37% achieved within 238 days.

Jennifer Kim’s has documented 94 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PGEN, Precigen at 26-Sep-2025.

Wall Street Analyst Jennifer Kim

Analyst best performing recommendations are on BLTE (BELITE BIO ADR).
The best stock recommendation documented was for GRAY (GRAYBUG VISION) at 5/13/2021. The price target of $84 was fulfilled within 46 days with a profit of $33.46 (66.2%) receiving and performance score of 14.39.

Average potential price target upside

CKPT Checkpoint Therapeutics GRAY Graybug Vision INSM Insmed NOVN Novan AYTU Aytu BioScience PRQR ProQR Therapeutics BV ALLK Allakos PGEN Precigen EYPT Eyepoint Pharmaceuticals PSTX Poseida Therapeutics LPCN Lipocine OCGN Ocugen BLTE Belite Bio ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Jan-2025

$4.8

$0.54 (12.68%)

$4.8

11 months 21 days ago
(31-Mar-2025)

0/3 (0%)

$0.76 (18.81%)

Hold Since 11-Mar-2025

$4.1

$-0.16 (-3.76%)

1 years 13 days ago
(11-Mar-2025)

1/4 (25%)

$0.1 (2.50%)

45

Hold Since 10-Mar-2025

$4.1

$-0.16 (-3.76%)

$8

1 years 14 days ago
(10-Mar-2025)

2/4 (50%)

$0.12 (3.02%)

117

Buy Since 19-Jan-2021

2 years 7 months 9 days ago
(15-Aug-2023)

0/2 (0%)

$8.34 (125.23%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Jennifer Kim is most bullish on?

Potential upside of $0 has been obtained for PGEN (PRECIGEN)

What Year was the first public recommendation made by Jennifer Kim?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?